Batch: GF112025092 Key analytical results include: BPC-157 Assay Content: 15.51 mg BPC-157 Identification Retention Time: 0.997 TB-500 (Thymosin Beta-4) Assay Content: 15.41 mg TB-500 Identification Retention Time: 0.989 Bacterial Endotoxins: below 0.001 EU per mg Total Aerobic Microbial Count: not detected Total Yeast and Mold Count: not detected Independent heavy metal screening confirmed no detectable levels of arsenic, cadmium, cobalt, lead, nickel, mercury or vanadium
Studies have shown that the expression of the VRK2 gene is linked to depression risk, with its regulatory mechanisms demonstrating significant spatial specificity in affected individuals [311]
EvoPeak Ltd ACN 15 223 734 393 10 Manning st, South Brisbane, 1210, Queensland, Australia Australia's premium supplier of 3rd-party tested research peptides
Cancer Res 74 , 40994110 (2014)
Label reconstituted samples clearly with preparation date and concentration
At the time of this writing, no serious side effects have been linked to the topical use of copper peptides